Stereolithographic (SLA) 3D Printing of Oral Modified-Release Dosage Forms

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-024-Tuesday
• By: ROBLES MARTINEZ, Pamela (UCL School of Pharmacy, Pharmaceutics, London, United Kingdom)
• Co-author(s): Pamela Robles Martinez: Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
  Alvaro Goyanes Goyanes: FabRx Ltd., Kent, United Kingdom
  Jie Wang: Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
  Simon Gaisford: FabRx Ltd., Kent, United Kingdom;Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
  Abdul Basit: FabRx Ltd., Kent, United Kingdom;Pharmaceutics, UCL School of Pharmacy, London, United Kingdom
  
• Abstract:

  Backgrounds

  3D printing (3DP) is a popular technology that provides the ability to fabricate structures of precise geometries. Stereolithography (SLA) is a type of 3DP technology in which the production of the object is based on the solidification of a liquid resin by photopolymerization. 

  Aims

  Manufacture drug loaded tablets by SLA with two model
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login